Long-lived enzymatic metabolites of thromboxane B2 in the human circulation
Data up to Jan 2025
Total Citations Per Year
Abstract
References (15)
Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable Angina
1983 • 1,740 citations
A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened Stroke
1978 • 933 citations
Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.
1983 • 675 citations
Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects
1980 • 642 citations
Controlled trial of aspirin in cerebral ischemia.
1977 • 633 citations
Release of Prostaglandins and Thromboxane into the Coronary Circulation in Patients with Ischemic Heart Disease
1981 • 597 citations
Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease.
1983 • 464 citations
Metabolism of thromboxane B2 in man. Identification of twenty urinary metabolites.
1981 • 244 citations
Estimated rate of thromboxane secretion into the circulation of normal humans.
1986 • 234 citations
Elevation of thromboxane B2 levels in patients with classic and variant angina Pectoris.
1981 • 206 citations
Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus.
1985 • 200 citations
Synthesis and structure of the platelet aggregation factor thromboxane A2
1985 • 126 citations
Measurement of urinary 2,3-dinor-thromboxane B2 and thromboxane B2 using bonded-phase phenylboronic acid columns and capillary gas chromatography-negative-ion chemical ionization mass spectrometry
1985 • 100 citations
Coronary vascular occlusion mediated via thromboxane A2-prostaglandin endoperoxide receptor activation in vivo.
1986 • 87 citations
Profiles of prostaglandin metabolites in the human circulation
1982 • 37 citations